Pancreatic Cancer Phosphorylome and Potential Drug Networks

Phosphorylation, a common post-translational modification (PTM) that influences a protein’s activity, can be a deciding factor in the selection of chemotherapeutics for successful cancer treatment. Britton et al. (2014) have developed a proteomics workflow, SysQuant, that quantifies changes in pancreatic cancer phosphopeptides and their allied pathways. This information can highlight relevant drug sensitivities for onward treatment Read the rest of this article

The post Pancreatic Cancer Phosphorylome and Potential Drug Networks appeared first on Accelerating Science.

from http://ift.tt/1EQKmsd
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s